[{"trial_metadata": {"citation": "Lancet 2023; 402: 705\u201319", "drug_name": "Oral semaglutide", "phase": "Phase 3", "indication": "Overweight or obesity", "numeric_trial_duration": 68, "trial_duration": "68 weeks", "safety_population_definition": "Participants who received at least one dose of trial drug", "NCT Number": "NCT05035095", "Sponsor": "Novo Nordisk", "route of adminstration": "Oral"}, "baseline_table": [{"variable_label": "Age", "variable_label_raw": "Age, years", "categorical_label": "", "variable_type": "continuous", "units": "years", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 49, "sd": 13, "raw_value": "49 (13)"}}, {"variable_label": "Age", "variable_label_raw": "Age, years", "categorical_label": "", "variable_type": "continuous", "units": "years", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 50, "sd": 12, "raw_value": "50 (12)"}}, {"variable_label": "Sex", "variable_label_raw": "Female", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 247, "percent": 74, "mean": 0, "sd": 0, "raw_value": "247/334 (74%)"}}, {"variable_label": "Sex", "variable_label_raw": "Female", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 238, "percent": 71, "mean": 0, "sd": 0, "raw_value": "238/333 (71%)"}}, {"variable_label": "Sex", "variable_label_raw": "Male", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 87, "percent": 26, "mean": 0, "sd": 0, "raw_value": "87/334 (26%)"}}, {"variable_label": "Sex", "variable_label_raw": "Male", "categorical_label": "Sex", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 95, "percent": 29, "mean": 0, "sd": 0, "raw_value": "95/333 (29%)"}}, {"variable_label": "Race", "variable_label_raw": "Asian", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 36, "percent": 11, "mean": 0, "sd": 0, "raw_value": "36/334 (11%)"}}, {"variable_label": "Race", "variable_label_raw": "Asian", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 36, "percent": 11, "mean": 0, "sd": 0, "raw_value": "36/333 (11%)"}}, {"variable_label": "Race", "variable_label_raw": "Black or African American", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 21, "percent": 6, "mean": 0, "sd": 0, "raw_value": "21/334 (6%)"}}, {"variable_label": "Race", "variable_label_raw": "Black or African American", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 22, "percent": 7, "mean": 0, "sd": 0, "raw_value": "22/333 (7%)"}}, {"variable_label": "Race", "variable_label_raw": "White", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 246, "percent": 74, "mean": 0, "sd": 0, "raw_value": "246/334 (74%)"}}, {"variable_label": "Race", "variable_label_raw": "White", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 248, "percent": 74, "mean": 0, "sd": 0, "raw_value": "248/333 (74%)"}}, {"variable_label": "Race", "variable_label_raw": "Other*", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 31, "percent": 9, "mean": 0, "sd": 0, "raw_value": "31/334 (9%)"}}, {"variable_label": "Race", "variable_label_raw": "Other*", "categorical_label": "Race", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 27, "percent": 8, "mean": 0, "sd": 0, "raw_value": "27/333 (8%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Hispanic or Latino", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 14, "percent": 4, "mean": 0, "sd": 0, "raw_value": "14/334 (4%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Hispanic or Latino", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 13, "percent": 4, "mean": 0, "sd": 0, "raw_value": "13/333 (4%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Not Hispanic or Latino", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 288, "percent": 86, "mean": 0, "sd": 0, "raw_value": "288/334 (86%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Not Hispanic or Latino", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 296, "percent": 89, "mean": 0, "sd": 0, "raw_value": "296/333 (89%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Not reported", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 32, "percent": 10, "mean": 0, "sd": 0, "raw_value": "32/334 (10%)"}}, {"variable_label": "Ethnicity", "variable_label_raw": "Not reported", "categorical_label": "Ethnicity", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 24, "percent": 7, "mean": 0, "sd": 0, "raw_value": "24/333 (7%)"}}, {"variable_label": "Bodyweight", "variable_label_raw": "Bodyweight, kg", "categorical_label": "", "variable_type": "continuous", "units": "kg", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 104.5, "sd": 22, "raw_value": "104\u00b75 (22\u00b70)"}}, {"variable_label": "Bodyweight", "variable_label_raw": "Bodyweight, kg", "categorical_label": "", "variable_type": "continuous", "units": "kg", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 106.2, "sd": 22.3, "raw_value": "106\u00b72 (22\u00b73)"}}, {"variable_label": "BMI", "variable_label_raw": "BMI, kg/m2", "categorical_label": "", "variable_type": "continuous", "units": "kg/m2", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 37.3, "sd": 6.3, "raw_value": "37\u00b73 (6\u00b73)"}}, {"variable_label": "BMI", "variable_label_raw": "BMI, kg/m2", "categorical_label": "", "variable_type": "continuous", "units": "kg/m2", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 37.7, "sd": 6.8, "raw_value": "37\u00b77 (6\u00b78)"}}, {"variable_label": "Waist circumference", "variable_label_raw": "Waist circumference, cm", "categorical_label": "", "variable_type": "continuous", "units": "cm", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 112.6, "sd": 13.6, "raw_value": "112\u00b76 (13\u00b76)"}}, {"variable_label": "Waist circumference", "variable_label_raw": "Waist circumference, cm", "categorical_label": "", "variable_type": "continuous", "units": "cm", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 114.5, "sd": 15.4, "raw_value": "114\u00b75 (15\u00b74)"}}, {"variable_label": "HbA1c", "variable_label_raw": "HbA1c, %", "categorical_label": "", "variable_type": "continuous", "units": "%", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 5.6, "sd": 0.3, "raw_value": "5\u00b76 (0\u00b73)"}}, {"variable_label": "HbA1c", "variable_label_raw": "HbA1c, %", "categorical_label": "", "variable_type": "continuous", "units": "%", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 5.6, "sd": 0.3, "raw_value": "5\u00b76 (0\u00b73)"}}, {"variable_label": "HbA1c", "variable_label_raw": "HbA1c, mmol/mol", "categorical_label": "", "variable_type": "continuous", "units": "mmol/mol", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 37.5, "sd": 3.6, "raw_value": "37\u00b75 (3\u00b76)"}}, {"variable_label": "HbA1c", "variable_label_raw": "HbA1c, mmol/mol", "categorical_label": "", "variable_type": "continuous", "units": "mmol/mol", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 37.9, "sd": 3.7, "raw_value": "37\u00b79 (3\u00b77)"}}, {"variable_label": "Fasting plasma glucose", "variable_label_raw": "Fasting plasma glucose, mmol/L", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 333, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 5.4, "sd": 0.7, "raw_value": "5\u00b74 (0\u00b77); n=333"}}, {"variable_label": "Fasting plasma glucose", "variable_label_raw": "Fasting plasma glucose, mmol/L", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 331, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 5.5, "sd": 0.5, "raw_value": "5\u00b75 (0\u00b75); n=331"}}, {"variable_label": "Fasting serum insulin", "variable_label_raw": "Fasting serum insulin, geometric mean (CV), pmol/L", "categorical_label": "", "variable_type": "continuous", "units": "pmol/L", "arm_result": {"total_n": 296, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 93.7, "sd": 60.4, "raw_value": "93\u00b77 (60\u00b74); n=296"}}, {"variable_label": "Fasting serum insulin", "variable_label_raw": "Fasting serum insulin, geometric mean (CV), pmol/L", "categorical_label": "", "variable_type": "continuous", "units": "pmol/L", "arm_result": {"total_n": 299, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 92.7, "sd": 57.6, "raw_value": "92\u00b77 (57\u00b76); n=299"}}, {"variable_label": "Prediabetes", "variable_label_raw": "Prediabetes\u2020", "categorical_label": "", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 132, "percent": 40, "mean": 0, "sd": 0, "raw_value": "132/334 (40%)"}}, {"variable_label": "Prediabetes", "variable_label_raw": "Prediabetes\u2020", "categorical_label": "", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 130, "percent": 39, "mean": 0, "sd": 0, "raw_value": "130/333 (39%)"}}, {"variable_label": "Blood pressure", "variable_label_raw": "Systolic", "categorical_label": "Blood pressure", "variable_type": "continuous", "units": "mm Hg", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 129, "sd": 16, "raw_value": "129 (16)"}}, {"variable_label": "Blood pressure", "variable_label_raw": "Systolic", "categorical_label": "Blood pressure", "variable_type": "continuous", "units": "mm Hg", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 130, "sd": 15, "raw_value": "130 (15)"}}, {"variable_label": "Blood pressure", "variable_label_raw": "Diastolic", "categorical_label": "Blood pressure", "variable_type": "continuous", "units": "mm Hg", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 82, "sd": 11, "raw_value": "82 (11)"}}, {"variable_label": "Blood pressure", "variable_label_raw": "Diastolic", "categorical_label": "Blood pressure", "variable_type": "continuous", "units": "mm Hg", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 83, "sd": 11, "raw_value": "83 (11)"}}, {"variable_label": "Pulse", "variable_label_raw": "Pulse, bpm", "categorical_label": "", "variable_type": "continuous", "units": "bpm", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 71, "sd": 10, "raw_value": "71 (10)"}}, {"variable_label": "Pulse", "variable_label_raw": "Pulse, bpm", "categorical_label": "", "variable_type": "continuous", "units": "bpm", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 72, "sd": 10, "raw_value": "72 (10)"}}, {"variable_label": "Lipids", "variable_label_raw": "Total cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 332, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 5, "sd": 20.7, "raw_value": "5\u00b70 (20\u00b77); n=332"}}, {"variable_label": "Lipids", "variable_label_raw": "Total cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 4.9, "sd": 20.1, "raw_value": "4\u00b79 (20\u00b71); n=328"}}, {"variable_label": "Lipids", "variable_label_raw": "HDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 331, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 1.3, "sd": 24.7, "raw_value": "1\u00b73 (24\u00b77); n=331"}}, {"variable_label": "Lipids", "variable_label_raw": "HDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 326, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 1.3, "sd": 23.3, "raw_value": "1\u00b73 (23\u00b73); n=326"}}, {"variable_label": "Lipids", "variable_label_raw": "LDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 331, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 3, "sd": 31.1, "raw_value": "3\u00b70 (31\u00b71); n=331"}}, {"variable_label": "Lipids", "variable_label_raw": "LDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 326, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 2.8, "sd": 34, "raw_value": "2\u00b78 (34\u00b70); n=326"}}, {"variable_label": "Lipids", "variable_label_raw": "VLDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 332, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 0.6, "sd": 44.3, "raw_value": "0\u00b76 (44\u00b73); n=332"}}, {"variable_label": "Lipids", "variable_label_raw": "VLDL cholesterol", "categorical_label": "Lipids", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 0.6, "sd": 50.9, "raw_value": "0\u00b76 (50\u00b79); n=328"}}, {"variable_label": "Free fatty acids", "variable_label_raw": "Free fatty acids", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 296, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 0.4, "sd": 63.1, "raw_value": "0\u00b74 (63\u00b71); n=296"}}, {"variable_label": "Free fatty acids", "variable_label_raw": "Free fatty acids", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 299, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 0.4, "sd": 60.6, "raw_value": "0\u00b74 (60\u00b76); n=299"}}, {"variable_label": "Triglycerides", "variable_label_raw": "Triglycerides", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 332, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 1.4, "sd": 44.8, "raw_value": "1\u00b74 (44\u00b78); n=332"}}, {"variable_label": "Triglycerides", "variable_label_raw": "Triglycerides", "categorical_label": "", "variable_type": "continuous", "units": "mmol/L", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 1.4, "sd": 52.2, "raw_value": "1\u00b74 (52\u00b72); n=328"}}, {"variable_label": "High-sensitivity C-reactive protein", "variable_label_raw": "High-sensitivity C-reactive protein, geometric mean (CV), mg/dL", "categorical_label": "", "variable_type": "continuous", "units": "mg/dL", "arm_result": {"total_n": 333, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 3.4, "sd": 138, "raw_value": "3\u00b74 (138\u00b70); n=333"}}, {"variable_label": "High-sensitivity C-reactive protein", "variable_label_raw": "High-sensitivity C-reactive protein, geometric mean (CV), mg/dL", "categorical_label": "", "variable_type": "continuous", "units": "mg/dL", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 3.4, "sd": 143.3, "raw_value": "3\u00b74 (143\u00b73); n=328"}}, {"variable_label": "eGFR", "variable_label_raw": "eGFR, geometric mean (CV), mL/min per 1\u00b773 m\u00b2", "categorical_label": "", "variable_type": "continuous", "units": "mL/min per 1\u00b773 m\u00b2", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 96.1, "sd": 17, "raw_value": "96\u00b71 (17\u00b70)"}}, {"variable_label": "eGFR", "variable_label_raw": "eGFR, geometric mean (CV), mL/min per 1\u00b773 m\u00b2", "categorical_label": "", "variable_type": "continuous", "units": "mL/min per 1\u00b773 m\u00b2", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 93.3, "sd": 20.5, "raw_value": "93\u00b73 (20\u00b75)"}}, {"variable_label": "IWQOL-Lite-CT scores", "variable_label_raw": "Physical Function", "categorical_label": "IWQOL-Lite-CT scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 322, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 63.6, "sd": 22.4, "raw_value": "63\u00b76 (22\u00b74); n=322"}}, {"variable_label": "IWQOL-Lite-CT scores", "variable_label_raw": "Physical Function", "categorical_label": "IWQOL-Lite-CT scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 61.3, "sd": 22.9, "raw_value": "61\u00b73 (22\u00b79); n=328"}}, {"variable_label": "IWQOL-Lite-CT scores", "variable_label_raw": "Total", "categorical_label": "IWQOL-Lite-CT scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 322, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 62, "sd": 20.9, "raw_value": "62\u00b70 (20\u00b79); n=322"}}, {"variable_label": "IWQOL-Lite-CT scores", "variable_label_raw": "Total", "categorical_label": "IWQOL-Lite-CT scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 328, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 60.4, "sd": 19.9, "raw_value": "60\u00b74 (19\u00b79); n=328"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Physical Functioning", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 327, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 51.4, "sd": 7, "raw_value": "51\u00b74 (7\u00b70); n=327"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Physical Functioning", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 331, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 51, "sd": 7, "raw_value": "51\u00b70 (7\u00b70); n=331"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Physical Component Summary", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 327, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 51.4, "sd": 7.4, "raw_value": "51\u00b74 (7\u00b74); n=327"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Physical Component Summary", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 331, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 51, "sd": 7.4, "raw_value": "51\u00b70 (7\u00b74); n=331"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Mental Component Summary", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 327, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 0, "percent": 0, "mean": 54.8, "sd": 6.1, "raw_value": "54\u00b78 (6\u00b71); n=327"}}, {"variable_label": "SF-36v2 scores", "variable_label_raw": "Mental Component Summary", "categorical_label": "SF-36v2 scores", "variable_type": "continuous", "units": "", "arm_result": {"total_n": 331, "arm_label": "Placebo", "arm_role": "control", "n": 0, "percent": 0, "mean": 55.4, "sd": 5.6, "raw_value": "55\u00b74 (5\u00b76); n=331"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Hypertension", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 144, "percent": 43, "mean": 0, "sd": 0, "raw_value": "144/334 (43%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Hypertension", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 161, "percent": 48, "mean": 0, "sd": 0, "raw_value": "161/333 (48%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Dyslipidaemia", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 128, "percent": 38, "mean": 0, "sd": 0, "raw_value": "128/334 (38%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Dyslipidaemia", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 139, "percent": 42, "mean": 0, "sd": 0, "raw_value": "139/333 (42%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Obstructive sleep apnoea", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 45, "percent": 13, "mean": 0, "sd": 0, "raw_value": "45/334 (13%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Obstructive sleep apnoea", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 48, "percent": 14, "mean": 0, "sd": 0, "raw_value": "48/333 (14%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Knee or hip osteoarthritis", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 34, "percent": 10, "mean": 0, "sd": 0, "raw_value": "34/334 (10%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Knee or hip osteoarthritis", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 42, "percent": 13, "mean": 0, "sd": 0, "raw_value": "42/333 (13%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Asthma or chronic obstructive pulmonary disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 41, "percent": 12, "mean": 0, "sd": 0, "raw_value": "41/334 (12%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Asthma or chronic obstructive pulmonary disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 29, "percent": 9, "mean": 0, "sd": 0, "raw_value": "29/333 (9%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Thyroid disorder", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 33, "percent": 10, "mean": 0, "sd": 0, "raw_value": "33/334 (10%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Thyroid disorder", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 33, "percent": 10, "mean": 0, "sd": 0, "raw_value": "33/333 (10%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Glucose metabolism disorder", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 29, "percent": 9, "mean": 0, "sd": 0, "raw_value": "29/334 (9%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Glucose metabolism disorder", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 24, "percent": 7, "mean": 0, "sd": 0, "raw_value": "24/333 (7%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Liver disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 20, "percent": 6, "mean": 0, "sd": 0, "raw_value": "20/334 (6%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Liver disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 20, "percent": 6, "mean": 0, "sd": 0, "raw_value": "20/333 (6%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Gout", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 12, "percent": 4, "mean": 0, "sd": 0, "raw_value": "12/334 (4%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Gout", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 15, "percent": 5, "mean": 0, "sd": 0, "raw_value": "15/333 (5%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Reproductive system disorders", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 8, "percent": 2, "mean": 0, "sd": 0, "raw_value": "8/334 (2%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Reproductive system disorders", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 5, "percent": 2, "mean": 0, "sd": 0, "raw_value": "5/333 (2%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Coronary artery disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 6, "percent": 2, "mean": 0, "sd": 0, "raw_value": "6/334 (2%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Coronary artery disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 3, "percent": 1, "mean": 0, "sd": 0, "raw_value": "3/333 (1%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Kidney disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 4, "percent": 1, "mean": 0, "sd": 0, "raw_value": "4/334 (1%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Kidney disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 3, "percent": 1, "mean": 0, "sd": 0, "raw_value": "3/333 (1%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Cerebrovascular disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 1, "percent": 0, "mean": 0, "sd": 0, "raw_value": "1/334 (0%)"}}, {"variable_label": "Comorbidities at screening", "variable_label_raw": "Cerebrovascular disease", "categorical_label": "Comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 3, "percent": 1, "mean": 0, "sd": 0, "raw_value": "3/333 (1%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Five or more", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 12, "percent": 4, "mean": 0, "sd": 0, "raw_value": "12/334 (4%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Five or more", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 6, "percent": 2, "mean": 0, "sd": 0, "raw_value": "6/333 (2%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Four", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 12, "percent": 4, "mean": 0, "sd": 0, "raw_value": "12/334 (4%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Four", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 17, "percent": 5, "mean": 0, "sd": 0, "raw_value": "17/333 (5%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Three", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 40, "percent": 12, "mean": 0, "sd": 0, "raw_value": "40/334 (12%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Three", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 50, "percent": 15, "mean": 0, "sd": 0, "raw_value": "50/333 (15%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Two", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 90, "percent": 27, "mean": 0, "sd": 0, "raw_value": "90/334 (27%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "Two", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 87, "percent": 26, "mean": 0, "sd": 0, "raw_value": "87/333 (26%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "One", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 96, "percent": 29, "mean": 0, "sd": 0, "raw_value": "96/334 (29%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "One", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 100, "percent": 30, "mean": 0, "sd": 0, "raw_value": "100/333 (30%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "None", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 334, "arm_label": "Oral semaglutide 50 mg", "arm_role": "treatment", "n": 84, "percent": 25, "mean": 0, "sd": 0, "raw_value": "84/334 (25%)"}}, {"variable_label": "Number of comorbidities at screening", "variable_label_raw": "None", "categorical_label": "Number of comorbidities at screening", "variable_type": "categorical", "units": "", "arm_result": {"total_n": 333, "arm_label": "Placebo", "arm_role": "control", "n": 73, "percent": 22, "mean": 0, "sd": 0, "raw_value": "73/333 (22%)"}}], "ae_events": [{"AE_label_raw": "Any adverse events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 307, "percent_with_event": 92}}, {"AE_label_raw": "Any adverse events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 285, "percent_with_event": 86}}, {"AE_label_raw": "Serious adverse events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": true, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 32, "percent_with_event": 10}}, {"AE_label_raw": "Serious adverse events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": true, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 29, "percent_with_event": 9}}, {"AE_label_raw": "Adverse events leading to trial product discontinuation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": true, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 19, "percent_with_event": 6}}, {"AE_label_raw": "Adverse events leading to trial product discontinuation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": true, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 12, "percent_with_event": 4}}, {"AE_label_raw": "Gastrointestinal disorders", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 12, "percent_with_event": 4}}, {"AE_label_raw": "Gastrointestinal disorders", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 5, "percent_with_event": 2}}, {"AE_label_raw": "Fatal events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": true, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Fatal events", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": false, "is_serious_ae": false, "is_fatal": true, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Nausea", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 173, "percent_with_event": 52}}, {"AE_label_raw": "Nausea", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 51, "percent_with_event": 15}}, {"AE_label_raw": "COVID-19", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 120, "percent_with_event": 36}}, {"AE_label_raw": "COVID-19", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 116, "percent_with_event": 35}}, {"AE_label_raw": "Constipation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 92, "percent_with_event": 28}}, {"AE_label_raw": "Constipation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 50, "percent_with_event": 15}}, {"AE_label_raw": "Diarrhoea", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 89, "percent_with_event": 27}}, {"AE_label_raw": "Diarrhoea", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 56, "percent_with_event": 17}}, {"AE_label_raw": "Vomiting", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 80, "percent_with_event": 24}}, {"AE_label_raw": "Vomiting", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 12, "percent_with_event": 4}}, {"AE_label_raw": "Decreased appetite", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 56, "percent_with_event": 17}}, {"AE_label_raw": "Decreased appetite", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 24, "percent_with_event": 7}}, {"AE_label_raw": "Dyspepsia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 47, "percent_with_event": 14}}, {"AE_label_raw": "Dyspepsia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 17, "percent_with_event": 5}}, {"AE_label_raw": "Headache", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 46, "percent_with_event": 14}}, {"AE_label_raw": "Headache", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 29, "percent_with_event": 9}}, {"AE_label_raw": "Nasopharyngitis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 38, "percent_with_event": 11}}, {"AE_label_raw": "Nasopharyngitis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 49, "percent_with_event": 15}}, {"AE_label_raw": "Abdominal pain upper", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 32, "percent_with_event": 10}}, {"AE_label_raw": "Abdominal pain upper", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 12, "percent_with_event": 4}}, {"AE_label_raw": "Eructation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 32, "percent_with_event": 10}}, {"AE_label_raw": "Eructation", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 7, "percent_with_event": 2}}, {"AE_label_raw": "Gastro-oesophageal reflux disease", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 29, "percent_with_event": 9}}, {"AE_label_raw": "Gastro-oesophageal reflux disease", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 11, "percent_with_event": 3}}, {"AE_label_raw": "Dizziness", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 27, "percent_with_event": 8}}, {"AE_label_raw": "Dizziness", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 16, "percent_with_event": 5}}, {"AE_label_raw": "Influenza", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 26, "percent_with_event": 8}}, {"AE_label_raw": "Influenza", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 18, "percent_with_event": 5}}, {"AE_label_raw": "Abdominal distension", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 25, "percent_with_event": 7}}, {"AE_label_raw": "Abdominal distension", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 16, "percent_with_event": 5}}, {"AE_label_raw": "Fatigue", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 24, "percent_with_event": 7}}, {"AE_label_raw": "Fatigue", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 20, "percent_with_event": 6}}, {"AE_label_raw": "Alopecia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 23, "percent_with_event": 7}}, {"AE_label_raw": "Alopecia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 9, "percent_with_event": 3}}, {"AE_label_raw": "Abdominal pain", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 22, "percent_with_event": 7}}, {"AE_label_raw": "Abdominal pain", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 16, "percent_with_event": 5}}, {"AE_label_raw": "Arthralgia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 22, "percent_with_event": 7}}, {"AE_label_raw": "Arthralgia", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 38, "percent_with_event": 11}}, {"AE_label_raw": "Flatulence", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 19, "percent_with_event": 6}}, {"AE_label_raw": "Flatulence", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 13, "percent_with_event": 4}}, {"AE_label_raw": "Upper-respiratory-tract infection", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 19, "percent_with_event": 6}}, {"AE_label_raw": "Upper-respiratory-tract infection", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 20, "percent_with_event": 6}}, {"AE_label_raw": "Urinary-tract infection", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 19, "percent_with_event": 6}}, {"AE_label_raw": "Urinary-tract infection", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 8, "percent_with_event": 2}}, {"AE_label_raw": "Gastroenteritis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 18, "percent_with_event": 5}}, {"AE_label_raw": "Gastroenteritis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 10, "percent_with_event": 3}}, {"AE_label_raw": "Back pain", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 16, "percent_with_event": 5}}, {"AE_label_raw": "Back pain", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 24, "percent_with_event": 7}}, {"AE_label_raw": "Sinusitis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 12, "percent_with_event": 4}}, {"AE_label_raw": "Sinusitis", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 18, "percent_with_event": 5}}, {"AE_label_raw": "Hypertension", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 10, "percent_with_event": 3}}, {"AE_label_raw": "Hypertension", "event_category": "Adverse events reported in 5% of patients or more by MedDRA preferred term", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 22, "percent_with_event": 7}}, {"AE_label_raw": "Gastrointestinal disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 268, "percent_with_event": 80}}, {"AE_label_raw": "Gastrointestinal disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 154, "percent_with_event": 46}}, {"AE_label_raw": "Cardiovascular disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 39, "percent_with_event": 12}}, {"AE_label_raw": "Cardiovascular disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 44, "percent_with_event": 13}}, {"AE_label_raw": "Psychiatric disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 31, "percent_with_event": 9}}, {"AE_label_raw": "Psychiatric disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 34, "percent_with_event": 10}}, {"AE_label_raw": "Benign and malignant neoplasms", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 30, "percent_with_event": 9}}, {"AE_label_raw": "Benign and malignant neoplasms", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 17, "percent_with_event": 5}}, {"AE_label_raw": "Allergic reactions", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 26, "percent_with_event": 8}}, {"AE_label_raw": "Allergic reactions", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": false, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 17, "percent_with_event": 5}}, {"AE_label_raw": "Gallbladder-related disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 13, "percent_with_event": 4}}, {"AE_label_raw": "Gallbladder-related disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 4, "percent_with_event": 1}}, {"AE_label_raw": "Hepatobiliary disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 13, "percent_with_event": 4}}, {"AE_label_raw": "Hepatobiliary disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 4, "percent_with_event": 1}}, {"AE_label_raw": "Cholelithiasis", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 11, "percent_with_event": 3}}, {"AE_label_raw": "Cholelithiasis", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 4, "percent_with_event": 1}}, {"AE_label_raw": "Hepatic disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 6, "percent_with_event": 2}}, {"AE_label_raw": "Hepatic disorders", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 9, "percent_with_event": 3}}, {"AE_label_raw": "Malignant neoplasms", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 5, "percent_with_event": 1}}, {"AE_label_raw": "Malignant neoplasms", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 4, "percent_with_event": 1}}, {"AE_label_raw": "Hypoglycaemia", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 3, "percent_with_event": 1}}, {"AE_label_raw": "Hypoglycaemia", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 1, "percent_with_event": 0}}, {"AE_label_raw": "Acute pancreatitis", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Acute pancreatitis", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Acute renal failure", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Oral semaglutide 50 mg", "total_n": 334, "arm_role": "treatment", "n_with_event": 0, "percent_with_event": 0}}, {"AE_label_raw": "Acute renal failure", "event_category": "Safety areas of interest", "is_any_ae": true, "is_serious_ae": false, "is_fatal": false, "is_ae_leading_to_discontinuation": false, "is_aesi": true, "arm_result": {"arm_label": "Placebo", "total_n": 333, "arm_role": "control", "n_with_event": 2, "percent_with_event": 1}}]}]